Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-23-046844

Interim CEO & General Counsel gave up 8,851 shares (to pay taxes)

  • Interim CEO & General Counsel acquired 20,834 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Vogt Frederick G Interim CEO & General Counsel 2023-04-14 Option exercise +20,834 69,718 D
Vogt Frederick G Interim CEO & General Counsel 2023-04-14 Shares withheld for taxes −8,851 $5.64 $49,920 60,867 D
Derivatives
Vogt Frederick G Interim CEO & General Counsel 2023-04-14 Option exercise · Restricted Stock Units −20,834 145,841 D
Loading xslF345X04/tm2313085-3_4seq1.xml…